David W. Nassif

Companies

• Pharvaris N.V.Chief financial officer Mar 18, 2026 to now¹
• Pharvaris N.V.General counsel Mar 18, 2026 to now¹
• Sio Gene Therapies Inc.Board member Feb 10, 2022 to Feb 10, 2022²
• Sio Gene Therapies Inc.Chief executive officer Feb 10, 2022 to Feb 10, 2022²
• Sio Gene Therapies Inc.Chief financial officer Mar 22, 2021 to Feb 10, 2022³
• Sio Gene Therapies Inc.Principal Financial Officer Jul 2, 2019 to Jun 15, 2020⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PNPharvaris N.V. PHVS113,800 shares⁵$3.4M at $29.67Sep 21, 2026
• SGSio Gene Therapies Inc.45,244 shares⁶Dec 8, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 21, 2026Gift 500 shares of Pharvaris N.V.⁵
• Sep 21, 2026Sold 6,000 shares at $36.47 of Pharvaris N.V.⁵
• May 21, 2026Sold 10,000 shares at $30.31 of Pharvaris N.V.⁷
• Dec 8, 2021Shares withheld for tax 6,294 shares at $1.42 of Sio Gene Therapies Inc.⁶
• Dec 8, 2021Granted 17,534 shares of Sio Gene Therapies Inc.⁶